Progression-related Outcomes Overview In the realm of multiple sclerosis (MS), progression-related outcomes are vital indicators of disease advancement and treatment […]
Progression-related outcomes of teriflunomide in multiple sclerosis clinical trials Read Post »
Patient Population The study focuses on a specific demographic of former American football players who have experienced chronic pain and
Understanding Optic Neuromyelitis Optic neuromyelitis, also known as neuromyelitis optica (NMO), is an inflammatory condition primarily affecting the optic nerves
Disease Overview Anti-myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating condition that primarily affects the central nervous system. It
Disease associated with anti-myelin oligodendrocyte glycoprotein (MOGAD) Read Post »
Understanding Pediatric Multiple Sclerosis Pediatric multiple sclerosis (MS) is a complex neurological disorder that primarily affects children and adolescents, distinguishing
Update guide on pediatric multiple sclerosis Read Post »
Clinical Presentation Guillain-Barre syndrome (GBS) typically manifests as a rapid onset of motor weakness, often starting in the legs and
Participant Experiences Participants in the MODIFI trial expressed a range of emotions and reflections regarding their experiences with Eye Movement
Study Overview This study investigates the distinct clinical presentation, electrophysiological characteristics, and short-term outcomes associated with pediatric-onset autoimmune nodopathy, highlighting
Disease Mechanisms The pathophysiology of disease associated with anti-myelin oligodendrocyte glycoprotein, commonly referred to as MOGAD, revolves around the immune
Disease associated with anti-myelin oligodendrocyte glycoprotein (MOGAD) Read Post »
Understanding Pediatric Multiple Sclerosis Pediatric multiple sclerosis (MS) is a form of multiple sclerosis that occurs in children and adolescents.
Update guide on pediatric multiple sclerosis Read Post »
